Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis.
Babayemi Oluwaseun OlakundeIjeoma Maryjoy IfeorahDaniel Adedayo AdeyinkaOlubunmi A OlakundeTemitayo OgundipeJohn O OlawepoEchezona E EzeanoluePublished in: Tropical medicine and health (2024)
The majority of under-five children in Africa achieved seroprotection after completing three or four doses of HBV vaccine. However, the rate was lower among children living with HIV. This calls for interventions to timely identify and address nonresponse to HBV vaccine, particularly among immunosuppressed children.